Inventors:
Scott W. Woods - East Haven CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 31/195, A61K 31/221, A61K 31/42, A61P 25/18
Abstract:
The present invention relates to a method of treating schizophrenia prodrome in human subjects using a NMDA glycine site agonist, a glycine transporter-1 inhibitor or mixtures thereof, optionally in combination with a pharmaceutically acceptable additive, carrier or excipient.